VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,911,034 | -9.2% | 2,374,992 | +1.6% | 0.09% | +8.3% |
| Q2 2023 | $70,403,442 | -4.1% | 2,338,208 | +3.1% | 0.08% | -21.5% |
| Q1 2023 | $73,384,325 | +6.1% | 2,268,449 | -6.0% | 0.11% | -7.0% |
| Q4 2022 | $69,179,851 | -13.6% | 2,413,812 | -27.3% | 0.12% | -22.8% |
| Q3 2022 | $80,081,344 | +1.1% | 3,320,108 | +14.8% | 0.15% | +8.0% |
| Q2 2022 | $79,179,956 | -22.0% | 2,891,894 | +7.9% | 0.14% | -4.2% |
| Q1 2022 | $101,566,770 | +406167.1% | 2,679,099 | +334787.4% | 0.14% | – |
| Q4 2021 | $25,000 | +4.2% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $24,000 | -11.1% | 800 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | +3.8% | 800 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | -10.3% | 800 | 0.0% | 0.00% | – |
| Q4 2020 | $29,000 | -91.5% | 800 | -90.7% | 0.00% | -100.0% |
| Q3 2020 | $340,000 | -14.1% | 8,595 | -22.0% | 0.00% | 0.0% |
| Q2 2020 | $396,000 | +1984.2% | 11,018 | +1277.2% | 0.00% | – |
| Q1 2020 | $19,000 | -17.4% | 800 | 0.0% | 0.00% | – |
| Q4 2019 | $23,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |